Aquestive Therapeutics Inc. (NASDAQ: AQST)
$2.78
+0.1100 ( +4.12% ) 777.8K
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
Market Data
Open
$2.78
Previous close
$2.67
Volume
777.8K
Market cap
$252.18M
Day range
$2.65 - $2.80
52 week range
$1.25 - $6.23
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 11, 2024 |
10-k | Annual reports | 128 | Mar 05, 2024 |
8-k | 8K-related | 30 | Mar 05, 2024 |
8-k | 8K-related | 12 | Dec 08, 2023 |
8-k | 8K-related | 14 | Dec 05, 2023 |
8-k | 8K-related | 56 | Nov 08, 2023 |
8-k | 8K-related | 29 | Nov 06, 2023 |
10-q | Quarterly Reports | 92 | Nov 06, 2023 |
8-k | 8K-related | 18 | Nov 02, 2023 |
8-k | 8K-related | 14 | Oct 10, 2023 |